By Dani Kass ( November 16, 2015, 11:01 PM EST) -- Boehringer Ingelheim and Teva on Friday told a Connecticut federal judge that the direct purchasers accusing them in multidistrict litigation of scheming to keep generic versions of the stroke-prevention drug Aggrenox off the market won't cooperate in discovery, by refusing to search for more than three terms....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.